LEARN FROM LEADING C. DIFF EXPERTS
In the spirit of education and collaboration, we’re excited to announce our inaugural “Scientific Symposium,” debuting on Friday, November 15th, 2024. This virtual event will allow clinicians, scientists, nurses, pharmacists, and industry to intermingle and update each other during C. diff Awareness Month. The Symposium will also feature testimonials from C. diff patients and survivors.
Confirmed Speakers
-
Epidemiology: Defining the Problem
Alice Guh, MD, MPH -
Novel Small Molecule Treatment, REC-3964
Andrew Skinner, MD -
Diagnosis of CDI
Erik Dubberke, MD, MSPH -
Pathophysiology of C. difficile
Bruce Hirsch, MD -
Risk Factors for CDI
Vincent Young, MD, PhD -
Pediatric C. diff
Maribeth Nicholson, MD, MPH -
Infection Control
Cindy Hou, DO, MA, MBA, CIC, CPHQ, CPPS, FACOI, FACP, FIDSA, FAPIC -
Panel Discussion: The IDSA vs. ACG Guidelines for Antimicrobial Management of CDI
Paul Feuerstadt, MD, FACG, AGAF
Colleen Kelly, MD
Stuart Johnson, MD -
Introduction to the Microbiota; FMT vs. LBP
Glenn Tillotson, PhD, FIDSA, FCCP -
Fecal Microbiota, Live-JSLM
Sahil Khanna, MD -
RePreve: A pivotal trial of Lumen Bio’s new low-cost, convenient C. difficile preventative
Carl Mason, MD, MPH -
Ibezapolstat Preserves Key Clostridium leptum Species
Kevin Garey, PharmD -
Fecal Microbiota Spores, Live-BRPK
Jessica Allegretti, MD, MPH -
Enzyme Immunoassay (EIA) CDI diagnostic testing
Stuart Cohen, MD -
Health-Related Quality of Life with CDI
Christian John Lillis -
Vedanta’s Clinical Trials to prevent recurrent C. Diff Infections-Transforming the field with First Live Biotherapeutic Products
Steven Shiff, MD -
CRS3123: A Narrow Spectrum Agent for Treatment of CDI
Jon B. Bruss, MD, MSPH, MBA
SPONSOR THE SYMPOSIUM
View the event’s sponsorship prospectus here and contact Erin at erin@peggyfoundation.org for more information about sponsoring the Symposium.
